Complement Therapeutics GmbH
PrivateLast Round
Series A
Apr 17, 2023
Total Funding Raised
$84.36M
Company Overview
Complement Therapeutics GmbH is a clinical-stage biotechnology company that develops novel gene therapies and diagnostic platforms for diseases mediated by the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Complement Therapeutics GmbH Comparables
Compare Complement Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Bio | 86% | |
| Oculogenex | 83% | |
| Aviceda Therapeutics | 78% |
Complement Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 17, 2023 | ||||
| Seed | Feb 23, 2022 |
Complement Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A, Seed |
| Gimv | Series A |
| Seroba Life Sciences | Series A |
| Panakès Partners | Series A |
| Cambridge Innovation Capital | Series A |
| Hadean Ventures | Series A |
| BioGeneration Ventures | Series A, Seed |
Recent news
Latest coverage and updates
- attends_eventAug 19, 2026
Complement Therapeutics Ltd attended event Clinical Trials at the Summit on Jun 13th '26.
Complement Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Complement Therapeutics GmbH's valuation, stock price, and market status.
Is Complement Therapeutics a public or private company?
Complement Therapeutics is a private company.
What is the current stock price of Complement Therapeutics?
Complement Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Complement Therapeutics worth (valuation)?
Valuation information for Complement Therapeutics is not publicly available.
Can I buy Complement Therapeutics stock?
Complement Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Complement Therapeutics's last funding round?
Complement Therapeutics's most recent funding round was Series A on April 17, 2023.
Who are the main investors in Complement Therapeutics?
Key investors in Complement Therapeutics include Gimv.
Will Complement Therapeutics IPO soon?
No public IPO plans have been announced for Complement Therapeutics.
How can I track Complement Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Complement Therapeutics's secondary market activity and sign up for updates.